{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:24:39Z","timestamp":1792095879236,"version":"4.4.0"},"reference-count":73,"publisher":"Rockefeller University Press","issue":"9","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T00:00:00Z","timestamp":1646524800000},"content-version":"vor","delay-in-days":228,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009730","name":"Kom op tegen Kanker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Flemish Cancer Society"},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Amanda and Jonathan Eilian"},{"DOI":"10.13039\/501100005026","name":"Stichting Tegen Kanker","doi-asserted-by":"publisher","award":["2016-054"],"award-info":[{"award-number":["2016-054"]}],"id":[{"id":"10.13039\/501100005026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Foundation \u2013 Flanders","award":["1S47519N"],"award-info":[{"award-number":["1S47519N"]}]},{"name":"Research Foundation \u2013 Flanders","award":["1SD1620N"],"award-info":[{"award-number":["1SD1620N"]}]},{"name":"EuroPDX Consortium"},{"name":"Czech Academy of Sciences","award":["RVO 68378050"],"award-info":[{"award-number":["RVO 68378050"]}]},{"name":"Czech Academy of Sciences","award":["LM2018126"],"award-info":[{"award-number":["LM2018126"]}]},{"DOI":"10.13039\/501100001823","name":"Ministry of Education, Youth and Sports","doi-asserted-by":"publisher","award":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001789"],"award-info":[{"award-number":["CZ.02.1.01\/0.0\/0.0\/16_013\/0001789"]}],"id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Structural and Investment Funds"}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9,6]]},"abstract":"<jats:p>The ability to adapt to environmental stress, including therapeutic insult, contributes to tumor evolution and drug resistance. In suboptimal conditions, the integrated stress response (ISR) promotes survival by dampening cytosolic translation. We show that ISR-dependent survival also relies on a concomitant up-regulation of mitochondrial protein synthesis, a vulnerability that can be exploited using mitoribosome-targeting antibiotics. Accordingly, such agents sensitized to MAPK inhibition, thus preventing the development of resistance in BRAFV600E melanoma models. Additionally, this treatment compromised the growth of melanomas that exhibited elevated ISR activity and resistance to both immunotherapy and targeted therapy. In keeping with this, pharmacological inactivation of ISR, or silencing of ATF4, rescued the antitumoral response to the tetracyclines. Moreover, a melanoma patient exposed to doxycycline experienced complete and long-lasting response of a treatment-resistant lesion. Our study indicates that the repurposing of mitoribosome-targeting antibiotics offers a rational salvage strategy for targeted therapy in BRAF mutant melanoma and a therapeutic option for NRAS-driven and immunotherapy-resistant tumors.<\/jats:p>","DOI":"10.1084\/jem.20210571","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T02:21:30Z","timestamp":1623896490000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":59,"title":["Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma"],"prefix":"10.1084","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7191-4887","authenticated-orcid":true,"given":"Roberto","family":"Vendramin","sequence":"first","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4336-7107","authenticated-orcid":true,"given":"Vicky","family":"Katopodi","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-6227","authenticated-orcid":true,"given":"Sonia","family":"Cinque","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9353-8026","authenticated-orcid":true,"given":"Angelina","family":"Konnova","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7486-4715","authenticated-orcid":true,"given":"Zorica","family":"Knezevic","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-7171","authenticated-orcid":true,"given":"Sara","family":"Adnane","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3537-8217","authenticated-orcid":true,"given":"Yvessa","family":"Verheyden","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7642-0875","authenticated-orcid":true,"given":"Panagiotis","family":"Karras","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Cancer Biology, Center for Cancer Biology, Vlaams Instituut voor Biotechnologie, Leuven, Belgium 2"},{"name":"Department of Oncology, Laboratory for Molecular Cancer Biology, Katholieke Universiteit Leuven, Belgium 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5506-0893","authenticated-orcid":true,"given":"Ewout","family":"Demesmaeker","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-2003","authenticated-orcid":true,"given":"Francesca M.","family":"Bosisio","sequence":"additional","affiliation":[{"name":"Translational Cell and Tissue Research, Katholieke Universiteit Leuven, Belgium 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0009-5105","authenticated-orcid":true,"given":"Lukas","family":"Kucera","sequence":"additional","affiliation":[{"name":"Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-8904","authenticated-orcid":true,"given":"Jan","family":"Rozman","sequence":"additional","affiliation":[{"name":"Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Vestec, Czech Republic 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9389-8432","authenticated-orcid":true,"given":"Ivan","family":"Gladwyn-Ng","sequence":"additional","affiliation":[{"name":"Taconic Biosciences, Leverkusen, Germany 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-9103","authenticated-orcid":true,"given":"Lara","family":"Rizzotto","sequence":"additional","affiliation":[{"name":"Trace, Leuven Cancer Institute, Katholieke Universiteit Leuven, Belgium 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4487-0449","authenticated-orcid":true,"given":"Erik","family":"Dassi","sequence":"additional","affiliation":[{"name":"Laboratory of RNA Regulatory Networks, Department of Cellular, Computational and Integrative Biology, University of Trento, Trento, Italy 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1659-3552","authenticated-orcid":true,"given":"Stefania","family":"Millevoi","sequence":"additional","affiliation":[{"name":"Cancer Research Centre of Toulouse, Institut national de la sant\u00e9 et de la recherche m\u00e9dicale Joint Research Unit 1037, Toulouse, France 9"},{"name":"Universit\u00e9 Toulouse III Paul Sabatier, Toulouse, France 10"},{"name":"Laboratoire d\u2019Excellence \u201cTOUCAN,\u201d Toulouse, France 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-3284","authenticated-orcid":true,"given":"Oliver","family":"Bechter","sequence":"additional","affiliation":[{"name":"Department of General Medical Oncology, Leuven Cancer Institute, Universitair Ziekenhuis Leuven, Leuven, Belgium 12"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2433-9837","authenticated-orcid":true,"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[{"name":"Laboratory for Molecular Cancer Biology, Center for Cancer Biology, Vlaams Instituut voor Biotechnologie, Leuven, Belgium 2"},{"name":"Department of Oncology, Laboratory for Molecular Cancer Biology, Katholieke Universiteit Leuven, Belgium 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2898-748X","authenticated-orcid":true,"given":"Eleonora","family":"Leucci","sequence":"additional","affiliation":[{"name":"Laboratory for RNA Cancer Biology, Department of Oncology, Katholieke Universiteit Leuven, Leuven, Belgium 1"},{"name":"Trace, Leuven Cancer Institute, Katholieke Universiteit Leuven, Belgium 4"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"2023072706583833500_bib1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064561","article-title":"Doxycycline alters metabolism and proliferation of human cell lines","volume":"8","author":"Ahler","year":"2013","journal-title":"PLoS One."},{"key":"2023072706583833500_bib2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/febs.14608","article-title":"Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications","volume":"286","author":"Almanza","year":"2019","journal-title":"FEBS J."},{"key":"2023072706583833500_bib3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2125.2004.02087.x","article-title":"Effects of tetracycline on the pharmacokinetics of halofantrine in healthy volunteers","volume":"58","author":"Bassi","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2023072706583833500_bib4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nm.4472","article-title":"Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF\/MEK inhibitors","volume":"24","author":"Boshuizen","year":"2018","journal-title":"Nat. Med."},{"key":"2023072706583833500_bib5","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1038\/s41467-020-17739-8","article-title":"Reversal of pre-existing NGFR-driven tumor and immune therapy resistance","volume":"11","author":"Boshuizen","year":"2020","journal-title":"Nat. Commun."},{"key":"2023072706583833500_bib6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","article-title":"The great escape: tumour cell plasticity in resistance to targeted therapy","volume":"19","author":"Boumahdi","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072706583833500_bib7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1126\/science.1101902","article-title":"A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress","volume":"307","author":"Boyce","year":"2005","journal-title":"Science."},{"key":"2023072706583833500_bib8","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.bbamcr.2013.05.002","article-title":"Internal ribosome entry site-mediated translational regulation of ATF4 splice variant in mammalian unfolded protein response","volume":"1833","author":"Chan","year":"2013","journal-title":"Biochim. Biophys. Acta."},{"key":"2023072706583833500_bib9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s10863-012-9465-9","article-title":"Mitochondrial dysfunction and cancer metastasis","volume":"44","author":"Chen","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"2023072706583833500_bib10","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/0008-5472.CAN-06-3137","article-title":"Adaptation of energy metabolism in breast cancer brain metastases","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"2023072706583833500_bib11","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/s41467-019-10042-1","article-title":"Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun."},{"key":"2023072706583833500_bib12","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1021\/acs.jmedchem.7b01182","article-title":"Small Molecule Mitochondrial Uncouplers and Their Therapeutic Potential","volume":"61","author":"Childress","year":"2018","journal-title":"J. Med. Chem."},{"key":"2023072706583833500_bib13","doi-asserted-by":"publisher","first-page":"72415","DOI":"10.18632\/oncotarget.11719","article-title":"The mitochondrial translation machinery as a therapeutic target in Myc-driven lymphomas","volume":"7","author":"D\u2019Andrea","year":"2016","journal-title":"Oncotarget."},{"key":"2023072706583833500_bib14","doi-asserted-by":"publisher","DOI":"10.4161\/trla.27738","article-title":"AURA 2: Empowering discovery of post-transcriptional networks","volume":"2","author":"Dassi","year":"2014","journal-title":"Translation (Austin)."},{"key":"2023072706583833500_bib15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41556-020-0477-0","article-title":"Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing","volume":"22","author":"Davis","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"2023072706583833500_bib16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.semcancer.2017.05.002","article-title":"Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR","volume":"47","author":"Deng","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"2023072706583833500_bib17","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/2159-8290.CD-19-1059","article-title":"Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs","volume":"10","author":"Dobson","year":"2020","journal-title":"Cancer Discov."},{"key":"2023072706583833500_bib18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tibs.2020.11.001","article-title":"G-Quadruplexes in RNA Biology: Recent Advances and Future Directions","volume":"46","author":"Dumas","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"2023072706583833500_bib19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1101\/gad.290940.116","article-title":"Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma","volume":"31","author":"Falletta","year":"2017","journal-title":"Genes Dev."},{"key":"2023072706583833500_bib20","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science."},{"key":"2023072706583833500_bib21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1158\/2159-8290.CD-18-1489","article-title":"Molecular profiling reveals unique immune and metabolic features of melanoma brain metastases","volume":"9","author":"Fischer","year":"2019","journal-title":"Cancer Discov."},{"key":"2023072706583833500_bib22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf5371","article-title":"RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria","volume":"353","author":"Guo","year":"2016","journal-title":"Science."},{"key":"2023072706583833500_bib23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1\u03b1 and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell."},{"key":"2023072706583833500_bib24","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer."},{"key":"2023072706583833500_bib25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fphar.2019.00203","article-title":"Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells","volume":"10","author":"Jagust","year":"2019","journal-title":"Front. Pharmacol."},{"key":"2023072706583833500_bib26","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell."},{"key":"2023072706583833500_bib27","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-020-16352-z","article-title":"Translational control of breast cancer plasticity","volume":"11","author":"Jewer","year":"2020","journal-title":"Nat. Commun."},{"key":"2023072706583833500_bib28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006055","article-title":"Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells","volume":"5","author":"Kalghatgi","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2023072706583833500_bib29","doi-asserted-by":"publisher","first-page":"W676","DOI":"10.1093\/nar\/gkl253","article-title":"QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences","volume":"34","author":"Kikin","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"2023072706583833500_bib30","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41591-019-0367-9","article-title":"Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers","volume":"25","author":"Kinsey","year":"2019","journal-title":"Nat. Med."},{"key":"2023072706583833500_bib31","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nmeth.3965","article-title":"rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome","volume":"13","author":"Kwok","year":"2016","journal-title":"Nat. Methods."},{"key":"2023072706583833500_bib32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nmeth.3179","article-title":"Directed evolution of APEX2 for electron microscopy and proximity labeling","volume":"12","author":"Lam","year":"2015","journal-title":"Nat. Methods."},{"key":"2023072706583833500_bib33","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nature11538","article-title":"Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation","volume":"490","author":"Landsberg","year":"2012","journal-title":"Nature."},{"key":"2023072706583833500_bib34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/jamaoncol.2015.1184","article-title":"Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials","volume":"1","author":"Larkin","year":"2015","journal-title":"JAMA Oncol."},{"key":"2023072706583833500_bib35","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1124\/dmd.114.057778","article-title":"The metabolic drug-drug interaction profile of Dabrafenib: in vitro investigations and quantitative extrapolation of the P450-mediated DDI risk","volume":"42","author":"Lawrence","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"2023072706583833500_bib36","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1038\/s41467-020-15726-7","article-title":"Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"2023072706583833500_bib37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science."},{"key":"2023072706583833500_bib38","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bbrc.2016.11.047","article-title":"The integrated stress response and proteotoxicity in cancer therapy","volume":"482","author":"McConkey","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2023072706583833500_bib39","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/S1470-2045(18)30952-5","article-title":"Modulating the microbiome to improve therapeutic response in cancer","volume":"20","author":"McQuade","year":"2019","journal-title":"Lancet Oncol."},{"key":"2023072706583833500_bib40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/pcmr.12498","article-title":"The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations","volume":"29","author":"Meeth","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"2023072706583833500_bib41","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1158\/2159-8290.CD-17-1178","article-title":"Immunotherapy resistance by inflammation-induced dedifferentiation","volume":"8","author":"Mehta","year":"2018","journal-title":"Cancer Discov."},{"key":"2023072706583833500_bib42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000178","article-title":"Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways","volume":"17","author":"Min","year":"2019","journal-title":"PLoS Biol."},{"key":"2023072706583833500_bib43","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.celrep.2015.02.034","article-title":"Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research","volume":"10","author":"Moullan","year":"2015","journal-title":"Cell Rep."},{"key":"2023072706583833500_bib44","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"2023072706583833500_bib45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/2159-8290.CD-18-0348","article-title":"Er translocation of the mapk pathway drives therapy resistance in BRAF-mutant melanoma","volume":"9","author":"Ojha","year":"2019","journal-title":"Cancer Discov."},{"key":"2023072706583833500_bib46","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ccell.2021.01.011","article-title":"Melanoma models for the next generation of therapies","volume":"39","author":"Patton","year":"2021","journal-title":"Cancer Cell."},{"key":"2023072706583833500_bib47","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1158\/0008-5472.CAN-18-2864","article-title":"Genetic and environmental determinants of immune response to cutaneous melanoma","volume":"79","author":"Po\u017aniak","year":"2019","journal-title":"Cancer Res."},{"key":"2023072706583833500_bib48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072706583833500_bib49","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1083\/jcb.201702058","article-title":"Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals","volume":"216","author":"Quir\u00f3s","year":"2017","journal-title":"J. Cell Biol."},{"key":"2023072706583833500_bib50","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward Minimal Residual Disease-Directed Therapy in Melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell."},{"key":"2023072706583833500_bib51","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","article-title":"Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities","volume":"33","author":"Rambow","year":"2019","journal-title":"Genes Dev."},{"key":"2023072706583833500_bib52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan8723","article-title":"Therapeutic synergy between tigecycline and venetoclax in a preclinical model of MYC\/BCL2 double-hit B cell lymphoma","volume":"10","author":"Rav\u00e0","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"2023072706583833500_bib53","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1038\/onc.2014.372","article-title":"A stress-induced early innate response causes multidrug tolerance in melanoma","volume":"34","author":"Ravindran Menon","year":"2015","journal-title":"Oncogene."},{"key":"2023072706583833500_bib54","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1002\/cam4.845","article-title":"A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia","volume":"5","author":"Reed","year":"2016","journal-title":"Cancer Med."},{"key":"2023072706583833500_bib55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.cell.2016.09.003","article-title":"Mitochondrial Protein Synthesis Adapts to Influx of Nuclear-Encoded Protein","volume":"167","author":"Richter-Dennerlein","year":"2016","journal-title":"Cell."},{"key":"2023072706583833500_bib56","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","article-title":"Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells","volume":"23","author":"Roesch","year":"2013","journal-title":"Cancer Cell."},{"key":"2023072706583833500_bib57","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.4161\/cc.8.23.10086","article-title":"Role of ATF4 in regulation of autophagy and resistance to drugs and hypoxia","volume":"8","author":"Rzymski","year":"2009","journal-title":"Cell Cycle."},{"key":"2023072706583833500_bib58","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nmeth.1314","article-title":"SUnSET, a nonradioactive method to monitor protein synthesis","volume":"6","author":"Schmidt","year":"2009","journal-title":"Nat. Methods."},{"key":"2023072706583833500_bib59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","article-title":"A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations","volume":"141","author":"Sharma","year":"2010","journal-title":"Cell."},{"key":"2023072706583833500_bib60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"2023072706583833500_bib61","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.1038\/s41467-019-13360-6","article-title":"An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells","volume":"10","author":"Shen","year":"2019","journal-title":"Nat. Commun."},{"key":"2023072706583833500_bib62","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","article-title":"Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia","volume":"20","author":"\u0160krti\u0107","year":"2011","journal-title":"Cancer Cell."},{"key":"2023072706583833500_bib63","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"2023072706583833500_bib64","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1073\/pnas.1712064115","article-title":"Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance","volume":"114","author":"Su","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072706583833500_bib65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40478-019-0712-8","article-title":"Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis","volume":"7","author":"Sundstr\u00f8m","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"2023072706583833500_bib66","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","article-title":"Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis","volume":"84","author":"Tan","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2023072706583833500_bib67","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell."},{"key":"2023072706583833500_bib68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.15698\/cst2019.01.172","article-title":"Control of nucleolar stress and translational reprogramming by lncRNAs","volume":"3","author":"Verheyden","year":"2019","journal-title":"Cell Stress."},{"key":"2023072706583833500_bib69","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/pcmr.12591","article-title":"UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model","volume":"30","author":"Wang","year":"2017","journal-title":"Pigment Cell Melanoma Res."},{"key":"2023072706583833500_bib70","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072706583833500_bib71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1712","article-title":"Targeting mitochondria metabolism for cancer therapy","volume":"11","author":"Weinberg","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"2023072706583833500_bib72","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020105268","article-title":"Mitochondrial translation deficiency impairs NAD+ -mediated lysosomal acidification","volume":"40","author":"Yagi","year":"2021","journal-title":"EMBO J."},{"key":"2023072706583833500_bib73","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/15384101.2016.1241929","article-title":"Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer","volume":"16","author":"Zhang","year":"2017","journal-title":"Cell Cycle."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20210571\/1803821\/jem_20210571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20210571\/1803821\/jem_20210571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T03:14:56Z","timestamp":1690427696000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/218\/9\/e20210571\/212494\/Activation-of-the-integrated-stress-response"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9,6]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20210571","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.26.173492","asserted-by":"object"}]},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"article-number":"e20210571"}}